Patents by Inventor Albrecht Bufe

Albrecht Bufe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9950017
    Abstract: The present invention relates to a pharmaceutical composition which includes naturally occurring, non-transgenic isolated bacteria from the group of Lactococcus and Acinetobacter or fragments thereof or mixtures thereof, to such a bacterium as a medicament for the prevention and/or treatment of allergic or chronic inflammatory disorders and to a process for producing this composition.
    Type: Grant
    Filed: March 3, 2008
    Date of Patent: April 24, 2018
    Assignees: FORSCHUNGSZENTRUM BORSTEL, RUHR-UNIVERSITÄT BOCHUM
    Inventors: Albrecht Bufe, Otto Holst, Harald Renz, Erika Von Mutius, Johann Bauer, Nicole Blumer, Jennifer Debarry, Markus Ege, Susanne Friedrich, Holger Garn, Soren Gatermann, Anna Hanuszkiewicz, Holger Heine, Michael Wegmann
  • Publication number: 20160296596
    Abstract: A prophylactic antiallergenic composition includes at least one arabinogalactan or arabinogalactan protein. The arabinogalactan or arabinogalactan protein is isolated from a grass or corresponds in its structural arrangement to an arabinogalactan that can be isolated from a grass.
    Type: Application
    Filed: June 20, 2016
    Publication date: October 13, 2016
    Inventors: Marcus Peters, Marion Kauth, Albrecht Bufe, Otto Holst
  • Patent number: 9375444
    Abstract: A prophylactic antiallergenic composition includes at least one arabinogalactan or arabinogalactan protein. The arabinogalactan or arabinogalactan protein is isolated from a grass or corresponds in its structural arrangement to an arabinogalactan that can be isolated from a grass.
    Type: Grant
    Filed: October 21, 2013
    Date of Patent: June 28, 2016
    Assignees: PROTECTIMMUN GMBH, FORSCHUNGSZENTRUM BORSTEL
    Inventors: Marcus Peters, Marion Kauth, Albrecht Bufe, Otto Holst
  • Publication number: 20140154290
    Abstract: A prophylactic antiallergenic composition includes at least one arabinogalactan or arabinogalactan protein. The arabinogalactan or arabinogalactan protein is isolated from a grass or corresponds in its structural arrangement to an arabinogalactan that can be isolated from a grass.
    Type: Application
    Filed: October 21, 2013
    Publication date: June 5, 2014
    Applicants: FORSCHUNGSZENTRUM BORSTEL, PROTECTIMMUN GMBH
    Inventors: Marcus Peters, Marion Kauth, Albrecht Bufe, Otto Holst
  • Publication number: 20120128597
    Abstract: A prophylactic antiallergenic composition includes at least one arabinogalactan or arabinogalactan protein. The arabinogalactan or arabinogalactan protein is isolated from a grass or corresponds in its structural arrangement to an arabinogalactan that can be isolated from a grass.
    Type: Application
    Filed: August 14, 2009
    Publication date: May 24, 2012
    Applicants: Forschungszentrum Borstel, Protectimmun GmbH
    Inventors: Marcus Peters, Marion Kauth, Albrecht Bufe, Otto Holt
  • Publication number: 20080305089
    Abstract: The present invention relates to a pharmaceutical composition which includes naturally occurring, non-transgenic isolated bacteria from the group of Lactococcus and Acinetobacter or fragments thereof or mixtures thereof, to such a bacterium as a medicament for the prevention and/or treatment of allergic or chronic inflammatory disorders and to a process for producing this composition.
    Type: Application
    Filed: March 3, 2008
    Publication date: December 11, 2008
    Applicant: Protectimmun GmbH
    Inventors: Albrecht Bufe, Otto Holst, Harald Renz, Erika von Mutius, Johann Bauer, Nicole Blumer, Jennifer Debarry, Markus Ege, Susanne Friedrich, Holger Garn, Soren Gatermann, Anna Hanuszkiewicz, Holger Heine, Michael Wegmann
  • Publication number: 20080112983
    Abstract: The present invention describes a process for preparing an extract for the treatment of allergic diseases, in which process no heat is supplied during all of the preparation process, an extract which has been prepared by this process, and the use of this extract for preparing a medicament.
    Type: Application
    Filed: August 18, 2005
    Publication date: May 15, 2008
    Inventors: Albrecht Bufe, Otto Holst, Erika Von Mutius, Charlotte Braun-Fahrlander, Dennis Nowak, Josef Riedler
  • Patent number: 6919086
    Abstract: The invention relates to modified recombinant allergen mutants which can be obtained from recombinant allergens which are derived from allergens which can be obtained by extraction from natural raw materials such as pollen of the species Phleum pratense. While these modified recombinant allergens stimulate lymphocytes from patients who are allergic to pollent to proliferate and synthesize cytokines, they exhibit a markedly diminished ability to bind to the IgE antibodies which are present in the serum of the T lymphocyte donors and to grass pollen allergen-specific IgEs and can therefore be used for a specific, made-to-release allergy therapy.
    Type: Grant
    Filed: March 16, 1998
    Date of Patent: July 19, 2005
    Assignee: Merck Patent Gesellschaft mit
    Inventors: Helga Kahlert, Hans-Thomas Stüwe, Helmut Fiebig, Oliver Cromwell, Wolf-Meinhard Becker, Albrecht Bufe, Gabriele Schramm, Lothar Jäger, Wolf-Dieter Müller